Overview

The Japan Digital Health Market was valued at an estimated USD 12.73 billion in 2025 and is projected to reach approximately USD 63.36 billion by 2034, growing at a CAGR of 19.5% during the forecast period (2026-2034). The market is driven by increasing digital healthcare adoption, government initiatives, and growing demand for remote and connected care solutions. The market is shifting from traditional healthcare delivery toward AI- and robotics-enabled digital solutions, driven by workforce shortages, an aging population, and the need for greater operational efficiency and accessible care. Government policy continues to actively shape market development, with initiatives including Healthcare Policy 2025 increasingly integrating digital health solutions into Japan's national healthcare system, aimed at ensuring elderly citizens receive necessary care while improving overall system efficiency and accessibility. Despite Japan's strong general technological infrastructure, the market continues to face structural friction from insufficient interoperability between healthcare systems, outdated software, and a lack of standardized data formats, which together limit seamless integration of digital health solutions across providers. By region, the Kanto region, supported by Tokyo, held the largest share of the market in 2025, leading Japan's digital health advancement given its robust technology ecosystem. The Kansai region, anchored by Osaka, is projected to be the fastest-growing region during the forecast period.

Market Size & Share

Market Dynamics

KEY MARKET TREND:

Digital Therapeutics Approval, Domestic-Foreign Partnership Activity and AI-Robotics Workforce Substitution Emerging as Trends

• Digital therapeutics, software-based interventions used as an adjunct or alternative to conventional pharmaceutical treatment, continue gaining regulatory clearance in Japan across an expanding range of therapeutic indications, extending beyond the category's earlier, narrower initial approvals.
• International healthcare and technology companies continue establishing partnerships with established Japanese telemedicine and digital health providers, reflecting foreign market entrants' preference for local partnership over solo market entry given Japan's distinct regulatory and healthcare delivery environment.
• Japanese domestic technology conglomerates are increasingly acquiring specialized digital health startups directly, rather than relying solely on internal product development, reflecting growing recognition that startup-pace innovation is difficult to replicate within large, established corporate structures.
• According to Japan’s PMDA, approvals of digital therapeutics including CureApp SC for nicotine dependence (2020), CureApp HT for hypertension (2022), SusMed Med CBT-i for insomnia (2023), and CureApp AUD for alcohol dependence (2025) are supporting the expansion of Japan’s digital health market into condition-specific, clinically validated treatment solutions.

KEY MARKET DRIVER

Aging Population and Chronic Disease Burden Are the Key Drivers

• Japan's uniquely severe demographic transition, with approximately 28% of the population aged 65 and older as of 2025, directly drives demand for remote monitoring, home care, and efficiency-focused digital health solutions at a scale and urgency exceeding most other developed markets.
• The rising prevalence of chronic diseases, including diabetes and cardiovascular conditions, continues to expand demand for digital health tools capable of supporting ongoing disease management outside conventional in-person clinical encounters.
• Government initiatives, including Healthcare Policy 2025, continue actively integrating digital health solutions into Japan's national healthcare system, providing sustained policy tailwind for continued market investment and adoption.
• According to Japan’s Statistics Bureau, 36.24 million people aged 65 and over accounted for 29.3% of the country’s population in 2024, highlighting the growing need for digital health solutions that support remote monitoring, chronic disease management, and accessible care for Japan’s aging population.

KEY MARKET OPPORTUNITY

Digital Therapeutics Expansion, Foreign Market Entry Partnerships and Interoperability Solutions Create Opportunity

• Continued digital therapeutics regulatory clearance across an expanding range of conditions represents an opportunity for developers capable of navigating Japan's specific regulatory pathway for software-based therapeutic interventions.
• Growing international company interest in the Japanese digital health market, typically pursued through partnership with established local telemedicine and digital health providers, represents an opportunity for domestic Japanese companies capable of offering credible market entry pathways to foreign partners.
• Persistent interoperability challenges across Japan's healthcare system, stemming from outdated software and non-standardized data formats, represent a substantial opportunity for vendors capable of offering credible integration and data standardization solutions specifically.
• Shionogi launched ENDEAVORRIDE in Japan, a digital therapeutic application designed as an adjunctive treatment for pediatric ADHD, extending domestic digital therapeutics development into a pediatric indication distinct from the adult-focused applications that have characterized much of the category's earlier development. 

Japan Digital Health Market Size, 2025-2034 (USD Billion)

Segmentation Analysis

Analysis by Technology

Telehealthcare held the largest market share in 2025, supported by rising demand for remote healthcare services, growing adoption of virtual consultations and remote patient monitoring, improved access to medical expertise for patients in geographically dispersed and underserved areas, reduced travel requirements, greater convenience for elderly and mobility-limited patients, and the increasing integration of digital communication technologies into routine healthcare delivery, enabling more continuous, accessible, and patient-centered care.

mHealth is projected to grow at the fastest CAGR during the forecast period, supported by the expanding use of mobile health applications, virtual healthcare services, and remote patient monitoring, alongside increasing smartphone penetration, demand for convenient and accessible healthcare, greater emphasis on continuous health monitoring, and the integration of mobile technologies into preventive care, chronic disease management, and personalized healthcare delivery.

Technology categories include

                 ·           Telehealthcare (Dominating Segment)

                 ·           mHealth (Highest CAGR Segment)

                 ·           Health Analytics

                 ·           Digital Health Systems

Analysis by Component

Software held the largest market share in 2025, supported by the growing adoption of digital health platforms, electronic health applications, data-management systems, clinical decision-support tools, and healthcare analytics solutions that form the core technology layer for digital healthcare delivery, enabling healthcare providers to streamline workflows, manage and exchange patient information, improve clinical decision-making, support remote and connected care, and deliver more personalized and efficient healthcare services.

Services are projected to grow at the fastest CAGR during the forecast period, supported by increasing demand for implementation, integration, interoperability, consulting, maintenance, and technical support services as healthcare organizations seek to connect diverse digital health applications with existing IT systems, modernize fragmented infrastructure, improve data exchange across healthcare settings, address integration complexities, and ensure the effective deployment and ongoing operation of digital health technologies.

Component categories include

                 ·           Software (Dominating Segment)

                 ·           Services (Highest CAGR Segment)

                 ·           Hardware

Analysis by Application

Chronic Disease Management held the largest market share in 2025, supported by the growing burden of diabetes, cardiovascular diseases, and other long-term conditions that require continuous monitoring, medication management, regular follow-up, and sustained patient engagement, increasing the need for digital health solutions that help healthcare providers manage patients beyond conventional clinical settings and improve continuity of care.

Remote Patient Monitoring is projected to grow at the fastest CAGR during the forecast period, supported by increasing demand for convenient and continuous healthcare services, greater adoption of connected monitoring technologies, the growing need to manage patients outside traditional healthcare facilities, and rising demand for solutions that enable healthcare providers to monitor vital health indicators and support timely interventions for Japan’s aging and increasingly home-based patient population.

Application categories include

                 ·           Chronic Disease Management (Dominating Segment)

                 ·           Remote Patient Monitoring (Highest CAGR Segment)

                 ·           Others

Analysis by End-User

Healthcare Providers held the largest end-user share in 2025, supported by the central role of hospitals, clinics, and other healthcare facilities in adopting and integrating digital health technologies across clinical workflows, patient management, diagnosis, treatment, monitoring, and care coordination. Increasing digitalization of healthcare operations is also encouraging providers to adopt platforms, applications, analytics, and connected solutions to improve workflow efficiency, facilitate information exchange, strengthen clinical decision-making, and enhance continuity of patient care.

Patients & Home Care is projected to grow at the fastest CAGR during the forecast period, driven by increasing demand for remote monitoring, virtual consultations, home-based care, and connected health solutions that enable patients to receive and manage healthcare services outside traditional medical facilities. The expansion of home-based care, combined with the growing need for continuous monitoring and convenient access to healthcare, is encouraging greater adoption of digital health technologies among elderly and chronically ill patients, particularly for long-term disease management and routine health monitoring.

End-User categories include

                 ·           Healthcare Providers (Dominating Segment)

                 ·           Patients & Home Care (Highest CAGR Segment)

                 ·           Payers

By Region

Japan Digital Health Market Regional Analysis

Japan Digital Health Market Share 2025

North America

XX%

South America

XX%

Europe

XX%

Middle East Africa

XX%

Asia Pacific

XX%

Regional Analysis

The Kanto region, anchored by Tokyo, held the leading position in Japan’s digital health market, supported by its advanced technology ecosystem, strong presence of healthcare and technology companies, extensive network of hospitals and clinics, and concentration of digital health innovation and investment. The region’s well-developed healthcare infrastructure and strong connectivity between technology providers, medical institutions, and other healthcare stakeholders continue to support the adoption and integration of digital health solutions across the region.

The Kansai region, anchored by Osaka, is projected to experience the fastest growth during the forecast period, supported by the region’s expanding healthcare and technology ecosystem, increasing adoption of digital healthcare solutions, development of healthcare innovation initiatives, and growing integration of technology across medical and care-delivery settings. The region’s established healthcare infrastructure and strong concentration of medical institutions and technology-related activities are expected to support further adoption of digital health solutions across clinical and home-care environments.

Regions Covered

                 ·           Kanto (Largest Region)

                 ·           Kansai (Fastest-Growing Region)

                 ·           Chubu

                 ·           Rest of Japan

Market Share

The Japan Digital Health Market is consolidated, spanning domestic companies including OMRON Healthcare, which strengthened its digital-health portfolio through the acquisition of Life Log Technology, Otsuka Precision Health and Shionogi, which are expanding digital therapeutics, including Shionogi’s ENDEAVORRIDE for pediatric ADHD. NTT Data and Fujitsu compete across healthcare IT, data infrastructure, AI and digital transformation, while MICIN and CureApp focus on telemedicine and digital therapeutics, with LY Corporation providing platform-based healthcare services. International players including Siemens Healthineers, UnitedHealth Group, Microsoft, GE HealthCare, IBM, Teladoc Health and Medtronic maintain Japan operations across AI-enabled diagnostics, healthcare cloud, telehealth, digital infrastructure and remote monitoring. Competitive intensity is centered on digital therapeutics, healthcare AI, telemedicine and interoperability, with key success factors including regulatory capabilities, local partnerships, healthcare-system integration and solutions addressing Japan’s aging population.

Key Players

                 ·           OMRON Healthcare Co., Ltd. (Japan)

                 ·           Otsuka Precision Health, Inc. (Japan)

                 ·           Shionogi & Co., Ltd. (Japan)

                 ·           NTT Data Corporation (Japan)

                 ·           Fujitsu Limited (Japan)

                 ·           MICIN, Inc. (Japan)

                 ·           CureApp, Inc. (Japan)

                 ·           LY Corporation (Japan)

                 ·           Siemens Healthineers AG (Germany)

                 ·           UnitedHealth Group Incorporated (US)

                 ·           Microsoft Corporation (US)

                 ·           GE HealthCare Technologies Inc. (US)

                 ·           International Business Machines Corporation (US)

                 ·           Teladoc Health, Inc. (US)

                 ·           Medtronic plc (Ireland)

Recent Market Developments

• October 2025: OMRON Healthcare expanded its digital health presence in Japan by taking over JSR’s Heartnote ECG service business, strengthening its portfolio in remote ECG monitoring and digitally enabled cardiac care.
• June 2026: Shionogi launched ENDEAVORRIDE in Japan, a digital therapeutic app for pediatric ADHD, expanding the availability of prescription digital therapeutics and supporting the growth of Japan’s digital health market.

Frequently Asked Questions

Key Questions Answered

Request a Sample

1

What does Digital Health cover in Japan?

2

What is the CAGR of the Japan Digital Health Market?

3

Which technology leads the Japan Digital Health Market?

4

Which region dominates the Japan Digital Health Market?

5

Which application segment has the highest growth potential?

6

What are the latest trends in Japan

7

Who are the leading digital health companies active in Japan?

Why Choose IG Transformation

Speak to Analyst

Strong Industry Focus

Extensive Product Offerings

Customer Research Services

Robust Research Methodology

Comprehensive Reports

Latest Technological Developments

Value Chain Analysis

Potential Market Opportunities

Growth Dynamics

Quality Assurance

Post-sales Support

Regular Report Updates